Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Texas Fertility Center Lauds AMA Designation of Infertility as a Disease as Sign of Hope for Patients
  • USA - English


News provided by

Catalyst HCM, INC.

Jun 27, 2017, 10:30 ET

Share this article

Share toX

Share this article

Share toX

Kaylen Silverberg, M.D., founding partner and medical director of  the Texas Fertility Center
Kaylen Silverberg, M.D., founding partner and medical director of the Texas Fertility Center

Austin, Texas (PRWEB) June 27, 2017 -- The recent vote by the American Medication Association to align with the World Health Organization in recognizing infertility as a disease gives new hope to patients and hopefully sheds new light on the way health insurers, governments and the public view the disorder, says Kaylen Silverberg, M.D., an infertility expert and founding partner of Texas Fertility Center.

We are very pleased to see the AMA join WHO in determining that infertility is a disease, not an elective condition. Our hope is that insurance companies will expand coverage for at least the diagnosis, if not the treatment, of infertility.

Post this

“This designation is something we have been advocating for years,” says Silverberg of the AMA vote at its 2017 annual meeting. “We are very pleased to see the AMA join the WHO in determining that infertility is a disease, not an elective condition. Our hope is that insurance companies will now do what’s right and expand coverage for at least the diagnosis, if not the treatment, of infertility.”

The Toll of Infertility

More than one in eight couples in the United States struggles with infertility, according to the Centers for Disease Control and Prevention. Because health insurers have not recognized infertility as a disease, individuals and couples have been forced to pay for diagnosis and treatment costs out-of-pocket.

“At Texas Fertility Center, we recognize that our patients covered through employer-sponsored benefits programs pay the same health insurance premiums as their fellow employees, but they are unable to use their funds to cover the disease that affects them – infertility. Their colleagues can use their premium dollars to pay for the diagnosis and treatment of heart disease, diabetes, and even pediatric illnesses, while our patients have to pay out-of-pocket for their fertility care,” Silverberg points out. “And, the downstream effect can be devastating, not only in terms of financial burden, but also the psychological impact of not being able to start a family when they so desperately want one.”

Just ask Kristy Hurst of New Braunfels, Texas, who with her husband, Terry, found themselves greatly challenged by infertility issues. In addition to the emotional toll, the Hursts faced the financial burden of not being able to use insurance to cover the costs of treatment.

Now the mother of healthy sons, ages 7 and 11, Hurst hopes the AMA ruling will bring relief for other individuals and couples who have dreams of families. “It breaks my heart to think about how close our kids came to never existing at all, were it not for the fact that we were able to work out a way to find the money we needed to bring them into the world,” she says.

Infertility Diagnosis and Treatment Matter

Finding out what is wrong when someone cannot become pregnant or sustain a pregnancy is a major step in treatment, Silverberg says. But the stigma that infertility is really not a medical issue may prevent people from even seeking assistance.

“People suffering from infertility often feel isolated and are faced with statements such as, ‘This isn’t really a disease, so what are you worried about?',” he notes. “And those comments, plus the lack of recognition of the true state of this disease, further compound the psychological issues that our patients experience.”

Now that global and national organizations are coming to the table, Silverberg says, hopefully providers such as Texas Fertility Center and others will be able to tell their patients that their treatment costs are covered by insurance – the same as with any other disease. “We applaud the AMA for stepping up to the plate.”

Hurst echoes those comments.

“So many people may never get to see their dreams of parenthood fulfilled,” she says. “I hope this recognition of infertility as a disease leads to better insurance coverage for others who, like us, need fertility treatment to have a child.”

About Texas Fertility Center
Texas Fertility Center (TFC), one of the nation’s leading full-service infertility practices, provides advanced infertility and reproductive endocrinology services to patients throughout Texas, the Southwestern United States and the Americas. For over 30 years, TFC has been recognized nationally for outstanding pregnancy rates, cutting-edge laboratory procedures and innovative research programs. Texas Fertility Center has expanded to include five locations in North Austin, South Austin, Central Austin, Round Rock and San Antonio. TFC’s physicians co-founded Ovation Fertility™ and Ovation Fertility™ Genetics, one of the nation’s leading networks of IVF and genetics laboratories.

Amy Hall, Catalyst HCM, INC., http://www.catalysthcm.com/, +1 (214) 893-8214, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.